Burixafor hydrobromide is the hydrobromide salt of burixafor, a selective, orally active CXCR4 antagonist supplied as a research reagent for preclinical and in vitro studies of CXCR4-mediated biology, including cancer metastasis, angiogenesis, and hematopoietic stem cell mobilization.
- Selective CXCR4 antagonist for receptor-targeted studies.
- High purity (98.0%) suitable for research applications.
- Water soluble (≈50 mg/mL) with ultrasonic assistance.
- Solid, light yellow to yellow appearance for easy handling.
- Recommended storage at -20°C under nitrogen for stability.
- Available in small research quantity (10 MG).